Atlas Trials

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Clinical trial NCT06049680 · RECRUITING

Trial details

NCT number
NCT06049680
Sponsor
Fresenius Kabi
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Malnutrition, ChildMalnutritionEssential Fatty Acid Deficiency (EFAD)Parenteral Nutrition Associated Cholestasis
Start date
2024-10-28
Primary completion
2026-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.